The relationship between potency of oxidative stress and severity of dilated cardiomyopathy

Author(s): Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, et al.

Abstract

Background:It has been suggested that oxidative stress may have a role in the etiopathogenesis of congestive heart failure.

Objectives:To investigate and compare the oxidative-antioxidative status and oxidative stress index (OSI) of patients with idiopathic dilated cardiomyopathy (IDC) with those of healthy volunteers, and to determine the relationship between total antioxidant capacity (TAC) and ejection fraction (EF).

Methods:Twenty-eight patients with IDC and 24 control subjects were enrolled in the study. Antioxidative status was evaluated by measuring the TAC and the vitamin C and thiol levels in the plasma. Oxidative status was evaluated by measuring the total peroxide level. The per cent ratio of TAC to total peroxide level was accepted as the OSI. EF was measured using Simpson's method.

Results:TAC and vitamin C and thiol levels of plasma were found to be significantly lower in patients with IDC than in control subjects (P < 0.001). In contrast, total peroxide levels and OSIs were significantly higher in patients with IDC than in control subjects (P = 0.002 and P = 0.002, respectively). An important positive correlation was found between TAC and EF (r = 0.772; P < 0.001). On the other hand, significant negative correlations were found between EF and OSI and between EF and total peroxide levels in patients.

Conclusions:Oxidants are increased and antioxidants are decreased in patients with IDC; as a result, the oxidative-antioxidative balance is shifted to the oxidative side. There is a significant correlation between the potency of oxidative stress and the severity of IDC. It is believed that supplementation of antioxidants in the treatment of IDC may be helpful to these patients.

Similar Articles

Role of cytokines in rheumatoid arthritis

Author(s): Feldmann M, Brennan FM, Maini RN

Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients

Author(s): Blake DR, Hall ND, Treby DA, Halliwell B, Gutteridge JM

Serum antioxidants and risk of rheumatoid arthritis

Author(s): Heliövaara M, Knekt P, Aho K, Aaran RK, Alfthan G, et al.

Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis

Author(s): Mazzetti I, Grigolo B, Borzì RM, Meliconi R, Facchini A

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Author(s): Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.

Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients

Author(s): Ali AM, Habeeb RA, El-Azizi NO, Khattab DA, Abo-Shady RA, et al.

Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis

Author(s): Kamanli A, Naziroqlu M, Aydilek N, Hacievliyagil C

The glutathione defense system in the pathogenesis of rheumatoid arthritis

Author(s): Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ

Reactive oxygen species and superoxide dismutases: role in joint diseases

Author(s): Afonso V, Champy R, Mitrovic D, Collin P, Lomri A

Serum biochemical markers in rheumatoid arthritis

Author(s): Pallinti V, Ganesan N, Anbazhagan M, Rajasekhar G

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis

Author(s): Thiele GM, Duryee MJ, Anderson DR, Klassen LW, Mohring SM, et al.

Caffeic acid phenethyl ester modulates methotrexate-induced oxidative stress in testes of rat

Author(s): Armagan A, Uzar E, Uz E, Yilmaz HR, Kutluhan S, et al.

Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis

Author(s): Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, et al.

Induction of superoxide dismutase by molecular oxygen

Author(s): Gregory EM, Fridovich I

Overexpression of Extracellular Superoxide Dismutase Protects against Brain Injury Induced by Chronic Hypoxia

Author(s): Zaghloul N, Patel H, Codipilly C, Marambaud P, Dewey S, et al.

Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity

Author(s): Veselinovic M, Barudzic N, Vuletic M, Zivkovic V, Tomic-Lucic A, et al.

Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets

Author(s): Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, et al.

Oxidative stress in patients with rheumatoid arthritis

Author(s): García-González A, Gaxiola-Robles R, Zenteno-Savín T

[Oxidative stress biomarkers as indicator of chronic inflammatory joint diseases stage]

Author(s): Feijóo M, Túnez I, Ruiz A, Tasset I, Muñoz E, et al.

Antioxidant enzymes; possible mechanism of gold compound treatment in rheumatoid arthritis

Author(s): Kerimova AA, Atalay M, Yusifov EY, Kuprin SP, Kerimov TM

Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase

Author(s): Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, et al.

The source and significance of raised serum enzymes in rheumatoid arthritis

Author(s): Thompson PW, Houghton BJ, Clifford C, Jones DD, Whitaker KB, et al.